@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix chebi: . @prefix hgnc: . @prefix proteinModification: . @prefix psimod: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 belv:variantOf hgnc:6871; a proteinModification:, psimod:00696 . sub:_2 rdf:object sub:_1; rdf:predicate belv:decreases; rdf:subject chebi:49668; a rdf:Statement . sub:_3 occursIn: obo:CLO_0008009, species:9606; rdf:object sub:_2; rdf:predicate belv:increases; rdf:subject schem:INCB3619; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:gefitinib) -| p(HGNC:MAPK1,pmod(P,T,185))", "a(SCHEM:INCB3619) -> (a(CHEBI:gefitinib) -| p(HGNC:MAPK1,pmod(P,T,185)))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "As shown in Figure 7D, both 2 mM INCB3619 and 0.5 mM gefitinib significantly reduced ERK phosphorylation, while the combined effect is even more dramatic."; prov:wasQuotedFrom pubmed:16843264 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:16843264; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:01.854+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }